The FDA has released new data confirming breast implants relation to Anaplastic Large Cell Lymphoma (ALCL)
In 2011, the FDA released initial findings that suggested a link between breast implants and ALCL, a cancer of the immune system. In an updated statement, further research has helped confirm that there is in fact a link between implants and the rare cancer.
“Since 2011, we have strengthened our understanding of this condition and concur with the World Health Organization designation of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) as a rare T-cell lymphoma that can develop following breast implants,” states the FDA.
The FDA had data for 359 cases of ALCL that were linked directly to breast implants, with nine of those cases leading to death. A big note on the cases was that there was a stronger correlation between textured breast implants and cancer than cancer associated with smooth surfaces.
Of the 359 reported cases, 231 specified the texture of implants with 203 reporting being textured, while 28 were smooth implants.
While the FDA findings are significant, cancer from breast implants is quite rare, according to TIME.